NCT04303858 2026-04-01A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid TumorsHoffmann-La RochePhase 1 Completed189 enrolled